Results for tag: "Reactive Airway Disease Drug"

The Reactive Airway Disease Drug market is a subset of the larger Respiratory Drugs market. It includes drugs used to treat asthma, chronic obstructive pulmonary disease (COPD), and other airway diseases. These drugs are used to reduce inflammation, open airways, and reduce the frequency and severity of asthma attacks. They can be administered orally, through inhalers, or intravenously. Commonly used drugs include corticosteroids, bronchodilators, and leukotriene modifiers. The Reactive Airway Disease Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Merck & Co., AstraZeneca, Novartis, and Boehringer Ingelheim. Show Less Read more